Target intelligence / Profile preview

Basic transcription factor 3 pseudogene 11 (BTF3P11)

Target
BTF3P11
Molecular classification
Other (Processed pseudogene)
01

Overview

Basic transcription factor 3 pseudogene 11 (BTF3P11) is a processed pseudogene in the human genome, not known to produce a functional protein. Some of its aliases (OPG, OCIF, TNFRSF11B) actually refer to the functional protein osteoprotegerin, encoded by the TNFRSF11B gene—a distinct entity with a well-established role in bone metabolism and disease. There is no evidence that BTF3P11 encodes a therapeutic target or participates in known biological pathways. The inclusion of "TNFRSF11B, OPG, OCIF" as aliases for BTF3P11 is a nomenclature artifact; these names correctly belong to the osteoprotegerin gene (TNFRSF11B). Key explanation and caution: - BTF3P11 is a pseudogene and not a valid therapeutic target; the commonly listed aliases (OPG, OCIF, TNFRSF11B) refer to a completely different protein-coding gene, which is a true receptor (Osteoprotegerin, encoded by TNFRSF11B). - There is likely a confusion in databases where aliases from TNFRSF11B are incorrectly attached to BTF3P11. - For data curation and therapeutic target selection, information about osteoprotegerin/TNFRSF11B should not be attributed to BTF3P11. If you are seeking information on Osteoprotegerin (OPG/TNFRSF11B), a genuine soluble receptor with therapeutic and biomarker significance, you should refer directly to the TNFRSF11B gene and ignore the BTF3P11 pseudogene entry.

Other names
lambda h27ABTF3 homologueBRF3L1BTF3L1HUMBTFBOCIFOPGTNFRSF11B

Beyond the preview

Go deeper on Basic transcription factor 3 pseudogene 11 (BTF3P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic transcription factor 3 pseudogene 11 (BTF3P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call